Evidence indicated the direct relationship between symptoms, MAO-B activity in platelets and the cerebrospinal fluid (CSF) monoamine metabolites revealed the significance of MAO-B expression in the platelets as the pathological marker of AD. Here, MAOB is linked to Alzheimer disease.